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ABSTRACT
Background: The presence of a fistula has usually been a
factor predicting high conversion and complication rates
following laparoscopic procedures for Crohn’s disease
and diverticulitis.
Methods: We studied retrospective data collected from
the medical case notes of patients. A single surgeon car-
ried out all these procedures from 1991 through 2001.
Results: Fourteen patients underwent 15 procedures. Six
patients were males and 8 were females. The diagnosis
was Crohn’s disease in 10 patients and diverticulitis in 4.
In 10 cases, the operation was the primary procedure, but
5 procedures were for recurrences. Two patients with
diverticulitis and 3 with Crohn’s disease had only the
fistulae divided with the application of an Endo-GIA sta-
pler across the fistulae (stapled fistulectomy). No bowel
resections were carried out in these 5 patients. Four cases
had to be converted due to bleeding (23%). The only
postoperative complication was a single case of wound
infection after conversion.
Conclusion: The presence of a fistula isn’t necessarily an
indication for conversion. If it is possible to dissect the
loops free, we believe that a stapled fistulectomy is effec-
tive with a low incidence of fistula recurrence, especially
in Crohn’s disease.
Key Words: Management of benign bowel fistulas.
INTRODUCTION
Laparoscopic resections in diverticulitis and Crohn’s dis-
ease have been shown to be safe and effective with
considerable benefits to patients.1–3 In most series that
have been published so far, the presence of a fistula has
usually been associated with a high conversion rate and a
high rate of complications.4–6
The exact mechanism of fistula formation in Crohn’s dis-
ease is still not clear, but both Crohn’ disease and diver-
ticulitis result from the extension of transmural inflamma-
tion into adjacent tissues. The fistula is internal if the
communication is with another intraabdominal organ or ex-
ternal if it is with the skin.7 Usually only 1 diseased bowel
segment is present, and the other bowel segment or the
other organ is a “victim” of the process of extension.8
In some patients, the fistula may be the sole indication for
the procedure, but usually enteroenteric or enterocolic
fistulas are incidental operative findings.7
METHODS
The data were retrospectively collected from the medical
case notes of the patients who had undergone laparo-
scopic surgery for bowel fistulas secondary to inflamma-
tory conditions of the small and large intestine. A single
surgeon carried out these procedures in the period be-
tween 1991 and 2001. All procedures were laparoscopic-
assisted. The bowel was mobilized intracorporeally and
then exteriorized through a 5-cm to 7-cm incision in the
iliac fossae or through the lower end of a previous midline
incision. The mesenteric vascular division and bowel re-
section was then carried out extracorporeally. Recently,
the vascular division has been carried out intracorpore-
ally. Bowel anastomosis was carried out either by a hand-
sewn or stapled technique. In cases of left-sided resec-
tions, the rectum was stapled at the appropriate length,
the diseased segment was exteriorized, the proximal
bowel was stapled, a CEEA anvil was introduced into the
proximal bowel loop, the bowel was then restored back
into the abdomen, and pneumoperitoneum was reintro-
duced. The stapler was then introduced through the rec-
tum and bowel continuity established. “Stapled fistulec-
tomy” (Figure 1) was carried out by dissecting the plane
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SCIENTIFIC PAPERbetween the diseased bowel segment and the victim
bowel/organ, the fistula was identified, and an Endo-GIA
stapler was used to transect the fistula. Univariate analysis
of the factors predictive of conversion was done using
Mann-Whitney and chi-square tests.
RESULTS
Fourteen patients underwent 15 procedures. Six patients
were males and 8 were females. The diagnosis was
Crohn’s disease in 10 cases and diverticulitis in 4. All
patients had their fistulas diagnosed preoperatively. Inves-
tigations consisted of Barium studies, colonoscopy, and
computed tomography scan where appropriate. Among
those patients with Crohn’s disease, the fistulas were ileo-
colic in 3 cases, ileo-cutaneous in 1, colocutaneous in 1,
colovesical in 1, ileo-vaginal in 1, and ileo-ileal in 3. The
fistulas were colovesical in 4 and colovaginal in 1 amongst
the cases with diverticulitis.
In 10 cases, the operation was the primary procedure, but
5 cases were for recurrences. Four procedures were per-
formed after previous resections for Crohn’s disease and
one after the laparoscopic management of a colovesical
fistula secondary to diverticulitis where only the fistula
was divided with an Endo-GIA stapler.
All patients had normal inflammatory markers. Table 1
gives the details of all the fistulas present in these patients
with information about the procedure that was performed.
The mean blood loss was 238.4 mL (standard deviation,
155.6; median, 200). The mean operating time was 119.2
minutes (standard deviation, 38.93; median, 120).
Four cases had to be converted due to bleeding (23%). One
was in a patient with diverticular disease who had a recur-
rence of his colovesical fistula. The other 3 conversions were
in patients with Crohn’s disease who had ileal fistulas, 2 of
whom were being operated on for disease recurrence hav-
ing had resections in the past. On univariate analysis, the
factors predictive of conversion were the presence of a mass
on clinical examination and surgery for recurrence.
Figure 1. “Stapled fistulectomy.”
Table 1.
Fistula Causes, Treatment, and Recurrence
Cause Type of Fistula Procedure Recurrence of
Fistula
Recurrence of
Disease
Diverticulitis Colovaginal 1 Division of fistula 1 Nil Nil
Colovesical 4 Sigmoid colectomy 3 Nil Nil
Division of fistula 1 1 Nil
Crohn’s Ileocolic 3 Right hemicolectomy 1 Nil Nil
Division of fistula 2 Nil 2
Ileovaginal 1 Right hemicolectomy Nil Nil
Ileocutaneous 1 Right hemicolectomy Nil Nil
Ileoileal 3 Right hemicolectomy 1 Nil Nil
Small intestine resection Stricture 1 Nil Nil
Division of fistula Defunctioning ileostomy 1 Nil Nil
Colovesical 1 Division of fistula Nil Nil
Colocutaneous 1 Left hemicolectomy Nil Nil
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a colovesical fistula was the only postoperative complica-
tion.
DISCUSSION
The difficulty in dissecting the plane between the in-
flamed bowel and the other loop into which the fistulizing
has occurred (victim loop) often necessitates conversion
or the resection of both loops of bowel. This is not necessary,
and an attempt should be made to dissect this plane and
transect the fistula to enable resection of the diseased loop
and closure of the hole in the “victim” loop.8
In our earlier smaller series9 of patients with Crohn’s
disease undergoing laparoscopic surgery, we commented
that division of the fistula with the help of an Endo-GIA
stapler was associated with no recurrences after a median
follow-up of 24 months. Since then with further follow-up
(median, 59 months), the fistulas have not recurred
though the inflammation has in 2 patients. One patient is
still under treatment for disease recurrence. This patient
had a biologically aggressive form of the disease, and
before division of the fistula had already had a laparo-
scopic left anterior resection and a right hemicolectomy.
The idea of a stapled fistulectomy has been suggested earli-
er.10 Especially now, with accumulating evidence that newer
treatment modalities such as Infliximab11 may be effective in
treating bowel fistulae in patients with Crohn’s disease, it is
likely that a laparoscopic stapled fistulectomy could be fol-
lowed by the administration of these newer antiinflamma-
tory agents or that this minimally invasive procedure could
be reserved for those fistulas refractory to these agents.
However, this would only be possible if dissection in the
plane between the affected loop and the other organ is
possible. It will also be essential to ensure that no stric-
tures are present distal to the fistula, preoperatively. This
is especially pertinent to laparoscopic surgery as tactile
sensation is lost. Of the 2 cases with sigmoid diverticulitis
where a stapled fistulectomy was attempted, the fistula
recurred in 1 patient with a colovesical fistula and was
managed by a sigmoid resection.
The conversion rate of 23% in our series is nearly compa-
rable to the rates reported.5,6 This rate is probably high
because of the presence of a mass in 3 of the 4 cases that
had to be converted and because a third of the cases
underwent surgery for recurrence. Canin-Endres et al2
commented on the high conversion rate in those cases of
Crohn’s disease where fistulas exist in combination with
the presence of a mass.
The complication rate in our series is extremely low with
only 1 case of postoperative wound infection. This is even
lower than the rates reported in the literature so far.12 This
small series of patients demonstrates that when laparo-
scopic surgery is attempted by an experienced surgeon,
the incidence of adverse effects can be reduced.
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